SARS-CoV-2 Membrane protein and other whole-virion antigens (SARS-CoV-2 M/Whole-Virion)

The SARS-CoV-2 Membrane (M) protein is the most abundant structural protein of the virus, serving as the central organizer of viral assembly through its interactions with the Spike (S), Envelope (E), and Nucleocapsid (N) proteins (UniProt: P0DTC5). In the context of whole-virion antigens, the M protein is a key component of inactivated vaccine platforms, which present the entire viral proteome to the host immune system to elicit a broad, multi-antigenic response (PubMed: 33301246). Unlike Spike-only vaccines, whole-virion approaches leverage the conserved nature of the M and N proteins, which may provide more stable targets across emerging viral variants (PubMed: 32835251). These antigens are critical for the structural integrity of the virion and are involved in the budding process from the host cell's endoplasmic reticulum-Golgi intermediate compartment (ERGIC). From a therapeutic perspective, targeting the full suite of virion antigens via inactivated vaccines like CoronaVac or BBV152 aims to mimic the antigenic breadth of natural infection while maintaining a high safety profile (PubMed: 34135381). This strategy is particularly relevant for addressing variants that escape Spike-specific neutralizing antibodies. Additionally, the M protein serves as a significant diagnostic marker for assessing the total immune response to SARS-CoV-2.

Other names

SARS-CoV-2 M proteinSARS-CoV-2 Matrix proteinInactivated SARS-CoV-2Whole-virion SARS-CoV-2 antigensSARS-CoV-2 structural proteins

Inactivated whole-virion vaccines present the Membrane (M), Envelope (E), Spike (S), and Nucleocapsid (N) proteins to the immune system, inducing a broad polyclonal antibody response and T-cell activation against multiple viral components (PubMed: 33301246).